Enjoy, and see you soon… A fast-growing group of Americans is turning to what many call the “gray market” for obesity ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

On Monday, Pharmalot's Ed Silverman shocked the pharmaceutical business by returning from vacation and announcing that his blog was no more. Over the past two years, Pharmalot grew into the ...

Former Star-Ledger pharmaceuticals reporter Ed Silverman is considering reviving his blog, Pharmalot. He is now the legal owner of "Pharmalot.com" and is keeping the brand alive in the form of a ...

Pfizer will sell a biosimilar version of the Remicade rheumatoid arthritis treatment next month at a 15 percent discount off the list price of the brand-name drug.

FLICKR, VELKR0 Ed Silverman’s Pharmalot blog is back, with a new home at The Wall Street Journal.Earlier this year (January 2), the blog was shut down by its former parent company, UBM Canon, which ...

Nonetheless, the Pharmalot campus is engulfed by a healthy amount of snow and still more is falling. This is a good time, then, to pick up a cup of stimulation and get busy foraging for ...

Once again, another working week will soon draw to a close and - along with it - the latest iteration of Pharmalot. Yes, you got that right. After a brief, but rewarding stay here at The Wall ...

WIKIMEDIA, KEN HAWKINS Each day, Ed Silverman, a long-time blogger and reporter, would start his morning post on Pharmalot with the chipper greeting, “Pharmalot, Pharmalittle,” plus a few words on the ...